blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2947100

EP2947100 - Oral compositions for the treatment or the prevention of infections by E. Coli [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  13.03.2020
Database last updated on 30.09.2024
FormerThe patent has been granted
Status updated on  05.04.2019
FormerGrant of patent is intended
Status updated on  03.04.2019
FormerExamination is in progress
Status updated on  01.03.2019
FormerGrant of patent is intended
Status updated on  29.10.2018
FormerExamination is in progress
Status updated on  07.04.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Galenagen, LLC
800 Westchester Avenue, Suite 528
Rye Brook, NY 10573 / US
[2020/11]
Former [2019/19]For all designated states
Galenagen, LLC
411 Theodore Fremd Avenue, Suite 206
Rye, NY 10580 / US
Former [2017/22]For all designated states
Galenagen, LLC
411 Theodore Fremd Avenue, Suite 206
Rye, NY 10580 / US
Former [2015/48]For all designated states
Curelon LLC
411 Theodore Fremd Avenue, Suite 206s
Rye, NY 10580 / US
Inventor(s)01 / Fallon, Joan M.
411 Theodore Fremd Avenue
Suite 206S
Rye, NY 10580 / US
02 / Heil, Matthew
47 Timber Lake Road
Sherman Connecticut 06784 / US
03 / Fallon, James J.
11 Wampus Close
Armonk New York 10504 / US
 [2019/19]
Former [2015/48]01 / Fallon, Joan M.
1180 Midland Avenue
Bronxville New York, 10708 / US
02 / Heil, Matthew
47 Timber Lake Road
Sherman Connecticut 06784 / US
03 / Fallon, James J.
11 Wampus Close
Armonk New York 10504 / US
Representative(s)HGF
8th Floor
140 London Wall
London EC2Y 5DN / GB
[N/P]
Former [2019/19]HGF Limited
8th Floor
140 London Wall
London EC2Y 5DN / GB
Former [2015/48]Patent Boutique LLP
37 Vanbrugh Park
London SE3 7AA / GB
Application number, filing date15152332.106.01.2010
[2015/48]
Priority number, dateUS20090142718P06.01.2009         Original published format: US 142718 P
US20090153279P17.02.2009         Original published format: US 153279 P
US20090170856P20.04.2009         Original published format: US 170856 P
[2015/48]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2947100
Date:25.11.2015
Language:EN
[2015/48]
Type: B1 Patent specification 
No.:EP2947100
Date:08.05.2019
Language:EN
[2019/19]
Search report(s)(Supplementary) European search report - dispatched on:EP20.10.2015
ClassificationIPC:C07K17/00, A61K38/47, A61K38/48, A61K38/46, A61P31/04
[2015/48]
CPC:
A61K38/4826 (EP,US); A61K38/43 (GB,KR); A61K38/46 (GB);
A01N63/50 (EP,US); A61K35/12 (KR); A61K38/00 (KR);
A61K38/17 (KR); A61K38/1709 (GB); A61K38/465 (EP,US);
A61K38/47 (EP,US); A61K45/06 (EP,US); A61P1/02 (EP);
A61P1/12 (EP); A61P17/02 (EP); A61P31/02 (EP);
A61P31/04 (EP); C07K14/47 (GB); C07K17/00 (GB);
C12N11/18 (KR); Y02A50/30 (EP,US) (-)
C-Set:
A01N63/50, A01N63/50 (US,EP);
A61K38/465, A61K2300/00 (EP,US);
A61K38/47, A61K2300/00 (US,EP);
A61K38/4826, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2016/27]
Former [2015/48]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MK,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  SM,  TR 
TitleGerman:Orale Zusammensetzungen zur Behandlung oder Prävention von Infektionen durch E. Coli[2019/19]
English:Oral compositions for the treatment or the prevention of infections by E. Coli[2015/48]
French:Compositions orales pour le traitement ou la prévention d'infections par E. coli[2015/48]
Former [2015/48]Orale Zusammensetzungen zur Behandlung oder Prävention von Infektionen durch E. Coli
Examination procedure25.05.2016Amendment by applicant (claims and/or description)
25.05.2016Examination requested  [2016/27]
10.04.2017Despatch of a communication from the examining division (Time limit: M06)
03.10.2017Reply to a communication from the examining division
30.10.2018Communication of intention to grant the patent
27.02.2019Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
27.02.2019Fee for grant paid
27.02.2019Fee for publishing/printing paid
02.04.2019Information about intention to grant a patent
02.04.2019Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP10729467.0  / EP2373693
Opposition(s)11.02.2020No opposition filed within time limit [2020/16]
Fees paidRenewal fee
14.05.2015Renewal fee patent year 03
14.05.2015Renewal fee patent year 04
14.05.2015Renewal fee patent year 05
14.05.2015Renewal fee patent year 06
27.01.2016Renewal fee patent year 07
27.01.2017Renewal fee patent year 08
29.01.2018Renewal fee patent year 09
28.01.2019Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU06.01.2010
AT08.05.2019
CY08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
MC08.05.2019
MK08.05.2019
MT08.05.2019
PL08.05.2019
SE08.05.2019
SI08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
IS08.09.2019
PT08.09.2019
BE31.01.2020
[2022/31]
Former [2022/30]HU06.01.2010
AT08.05.2019
CY08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
MC08.05.2019
MT08.05.2019
PL08.05.2019
SE08.05.2019
SI08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
IS08.09.2019
PT08.09.2019
BE31.01.2020
Former [2022/28]HU06.01.2010
AT08.05.2019
CY08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
MC08.05.2019
MT08.05.2019
PL08.05.2019
SE08.05.2019
SI08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
BE31.01.2020
Former [2020/51]AT08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
MC08.05.2019
PL08.05.2019
SE08.05.2019
SI08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
BE31.01.2020
Former [2020/39]AT08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
MC08.05.2019
PL08.05.2019
SE08.05.2019
SI08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2020/25]AT08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
PL08.05.2019
SE08.05.2019
SI08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2020/17]AT08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
SE08.05.2019
SK08.05.2019
SM08.05.2019
TR08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2020/14]AT08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
SE08.05.2019
SK08.05.2019
SM08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2020/11]AT08.05.2019
CZ08.05.2019
DK08.05.2019
EE08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
SE08.05.2019
SK08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2020/09]CZ08.05.2019
DK08.05.2019
FI08.05.2019
LT08.05.2019
LV08.05.2019
SE08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2019/52]FI08.05.2019
LT08.05.2019
LV08.05.2019
SE08.05.2019
BG08.08.2019
NO08.08.2019
PT08.09.2019
Former [2019/48]FI08.05.2019
LT08.05.2019
SE08.05.2019
NO08.08.2019
PT08.09.2019
Former [2019/47]FI08.05.2019
LT08.05.2019
NO08.08.2019
Documents cited:Search[I]WO2006031554  (NOVOZYMES NORTH AMERICA INC [US], et al) [I] 1-15 * page 2, line 32 - page 3, line 4; example 4 *;
 [A]WO2006044529  (ALTUS PHARMACEUTICALS INC [US], et al) [A] 1-15 * abstract *;
 [A]US2006198838  (FALLON JOAN M [US]) [A] 1-15 * abstract *;
 [I]  - SERNA ANTONIO 4TH ET AL, "Pathogenesis and treatment of Shiga toxin-producing Escherichia coli infections.", CURRENT OPINION IN GASTROENTEROLOGY JAN 2008 LNKD- PUBMED:18043231, (200801), vol. 24, no. 1, ISSN 1531-7056, pages 38 - 47, XP009157370 [I] 1-15 * the whole document *

DOI:   http://dx.doi.org/10.1097/MOG.0b013e3282f2dfb8
by applicantUS3536809
 US3598123
 US3710795
 US3786615
 US3845770
 US3916899
 USRE28819E
 US4008719
 US4044126
 US4199322
 US4328245
 US4358603
 US4364923
 US4395454
 US4409239
 US4410545
 US4414209
 US4710384
 US5059595
 US5073543
 US5120548
 WO9219709
 WO9219708
 US5354556
 US5591767
 US5639476
 US5674533
 US5733566
 US5860957
 US5948433
 US5983134
 US5985317
 US6010715
 US6024975
 US6167301
 US6256533
 US6261595
 US6267983
    - Merck Index, MERCK & COMPANY
    - BAILEY; SCOTT, Diagnostic Microbiology, (1990), page 177
    - U.S. PHARMACOPEIA NATIONAL FORMULARY, (1990), pages 1857 - 1859
    - BARRY ET AL., Pharmacology of the Skin, KARGER, (1987), vol. 1, pages 121 - 137
    - BARRY, J. CONTROLLED RELEASE, (1987), vol. 6, pages 85 - 97
    - "Susceptibility testing of antimicrobials in liquid media", AMSTERDAM, D., Antibiotics in Laboratory Medicine, WILLIAMS AND WILKINS, (1996), pages 52 - 111
    - M7-A58, NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS (NCCLS
 US20090386051
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.